» Articles » PMID: 38001404

RTEL1 Gene Polymorphisms and Neuroblastoma Risk in Chinese Children

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2023 Nov 24
PMID 38001404
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neuroblastoma, a neuroendocrine tumor originating from the sympathetic ganglia, is one of the most common malignancies in childhood. RTEL1 is critical in many fundamental cellular processes, such as DNA replication, DNA damage repair, genomic integrity, and telomere stability. Single nucleotide polymorphisms (SNPs) in the RTEL1 gene have been reported to confer susceptibility to multiple cancers, but their contributing roles in neuroblastoma remain unclear.

Methods: We conducted a study on 402 neuroblastoma cases and 473 controls to assess the association between four RTEL1 SNPs (rs3761124 T>C, rs3848672 T>C, rs3208008 A>C and rs2297441 G>A) and neuroblastoma susceptibility.

Results: Our results show that rs3848672 T>C is significantly associated with an increased risk of neuroblastoma [CC vs. TT/TC: adjusted odds ratio (OR)=1.39, 95% confidence interval (CI)=1.02-1.90, P=0.038]. The stratified analysis further indicated that boy carriers of the rs3848672 CC genotype had a higher risk of neuroblastoma, and all carriers had an increased risk of developing neuroblastoma of mediastinum origin. Moreover, the rs2297441 AA genotype increased neuroblastoma risk in girls and predisposed children to neuroblastoma arising from retroperitoneal.

Conclusion: Our study indicated that the rs3848672 CC and rs2297441 AA genotypes of the RTEL1 gene are significantly associated with an increased risk of neuroblastoma in Chinese children in a gender- and site-specific manner.

Citing Articles

HOTTIP rs1859168 C > A polymorphism reduces neuroblastoma susceptibility in Chinese children.

Zhang T, Yin H, Guo J, Chang J, Li M, He J Eur J Pediatr. 2024; 184(1):104.

PMID: 39718648 DOI: 10.1007/s00431-024-05942-4.


A comprehensive in silico investigation into the pathogenic SNPs in the RTEL1 gene and their biological consequences.

Tanshee R, Mahmud Z, Nabi A, Sayem M PLoS One. 2024; 19(9):e0309713.

PMID: 39240887 PMC: 11379182. DOI: 10.1371/journal.pone.0309713.


Neuroblastoma susceptibility and association of N7-methylguanosine modification gene polymorphisms: multi-center case-control study.

Lin H, Liao F, Liu J, Yang Z, Zhang J, Cheng J Pediatr Res. 2024; 97(1):153-159.

PMID: 38871802 DOI: 10.1038/s41390-024-03318-w.

References
1.
Ziv A, Werner L, Konnikova L, Awad A, Jeske T, Hastreiter M . An RTEL1 Mutation Links to Infantile-Onset Ulcerative Colitis and Severe Immunodeficiency. J Clin Immunol. 2020; 40(7):1010-1019. DOI: 10.1007/s10875-020-00829-z. View

2.
Ward E, DeSantis C, Robbins A, Kohler B, Jemal A . Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2):83-103. DOI: 10.3322/caac.21219. View

3.
Egan K, Thompson R, Nabors L, Olson J, Brat D, LaRocca R . Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol. 2011; 104(2):535-42. PMC: 3138895. DOI: 10.1007/s11060-010-0506-0. View

4.
Yan S, Xia R, Jin T, Ren H, Yang H, Li J . RTEL1 polymorphisms are associated with lung cancer risk in the Chinese Han population. Oncotarget. 2016; 7(43):70475-70480. PMC: 5342566. DOI: 10.18632/oncotarget.12297. View

5.
Lin L, Deng C, Zhou C, Zhang X, Zhu J, Liu J . NSUN2 gene rs13181449 C>T polymorphism reduces neuroblastoma risk. Gene. 2022; 854:147120. DOI: 10.1016/j.gene.2022.147120. View